• Company
• ‘Switching between AD drugs’ discussed at NA audit
• by Whang, byung-woo Oct 11, 2024 05:54am

• Company
• Will Tevimbra be reimbursed promptly in Korea?
• by Eo, Yun-Ho Oct 11, 2024 05:54am

• Company
• SK bioscience invests KRW 4.1B stake in a U.S. biotech
• by Kim, Jin-Gu Oct 10, 2024 05:51am

• Company
• Who will distribute Mounjaro in Korea?
• by Whang, byung-woo Oct 10, 2024 05:50am

• Company
• Wegovy's release on the 15th…competitor Mounjaro
• by Whang, byung-woo Oct 8, 2024 05:49am

• Company
• Ilaris can be prescribed at general hospitals in KOR
• by Eo, Yun-Ho Oct 8, 2024 05:49am

• Company
• Eisai Korea signs Alzheimer's MOU with the Korean Dementia
• by Whang, byung-woo Oct 8, 2024 05:49am

• Company
• Galderma Korea appoints Jai Hyuk Lee as new GM
• by Whang, byung-woo Oct 8, 2024 05:48am

• Company
• Yuhan·Dongwha as potential distributor for Bayer's OTC drug
• by Nho, Byung Chul Oct 7, 2024 05:48am

• Company
• Darzalex seeks reimbursement extensions again in KOR
• by Whang, byung-woo Oct 7, 2024 05:48am